| Q34297774 | A frequent variant in the human bile salt export pump gene ABCB11 is associated with hepatitis C virus infection, but not liver stiffness in a German population |
| Q33972858 | A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease |
| Q35014462 | A single nucleotide polymorphism associated with hepatitis C virus infections located in the distal region of the IL28B promoter influences NF-κB-mediated gene transcription |
| Q42984292 | An analysis of tumor necrosis factor alpha gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection |
| Q34417123 | Association of IL-10, IL-4, and IL-28B gene polymorphisms with spontaneous clearance of hepatitis C virus in a population from Rio de Janeiro |
| Q43039746 | Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection |
| Q33867870 | CCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C. |
| Q34180954 | Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment |
| Q35101348 | Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection |
| Q61463933 | Cytokine Receptors in the Brain |
| Q23910025 | Cytokine polymorphisms play a role in susceptibility to ultraviolet B-induced modulation of immune responses after hepatitis B vaccination |
| Q42997726 | Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3. |
| Q37046063 | Effects of the -791(C→T) mutation in the promoter for tumor necrosis factor alpha on gene expression and resistance of Large White pigs to enterotoxigenic Escherichia coli F18. |
| Q27480999 | Factors Affecting Serum Concentrations of Hepatitis C Virus (HCV) RNA in HCV Genotype 1-Infected Patients with Chronic Hepatitis |
| Q38353652 | Genetic factors in mother-to-child transmission of HCV infection |
| Q37362755 | Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment. |
| Q57332116 | Genetic risk factors for infection in patients with early rheumatoid arthritis |
| Q34416280 | Genetic susceptibility in chronic viral hepatitis |
| Q43047613 | HLA class I B44 is associated with sustained response to interferon + ribavirin therapy in patients with chronic hepatitis C. |
| Q38056077 | Host factors determining the efficacy of hepatitis C treatment. |
| Q35753723 | Host genetic determinants in hepatitis C virus infection |
| Q58803426 | IL-10 and TNF-α polymorphisms and the recovery from HCV infection |
| Q80682842 | Impact of serum levels and gene polymorphism of cytokines on chronic hepatitis C infection |
| Q34805796 | Influence of Genetic Polymorphisms of Tumor Necrosis Factor Alpha and Interleukin 10 Genes on the Risk of Liver Cirrhosis in HIV-HCV Coinfected Patients |
| Q61971724 | Influence of TNFα gene polymorphisms on TNFα production and disease |
| Q40666389 | Influence of cytokine and cytokine receptor gene polymorphisms on the degree of liver damage in patients with chronic hepatitis C. |
| Q40626254 | Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy |
| Q35671253 | Is there a future for TNF promoter polymorphisms? |
| Q52542558 | Novel alleles at the lymphotoxin alpha (LTalpha) locus mark extended HLA haplotypes in native Africans. |
| Q33852630 | Polymorphism of the human TNF-alpha promoter--random variation or functional diversity? |
| Q50585022 | Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin. |
| Q47850386 | Polymorphisms in tumor necrosis factor and other cytokines as risks for infectious diseases and the septic syndrome |
| Q27488351 | TNF and LTA gene, allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais |
| Q84148682 | TNF-α and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk |
| Q75431905 | TNFalpha polymorphism frequencies in HPV-associated cervical dysplasia |
| Q50582759 | The Delta 32 mutation of the chemokine-receptor 5 gene neither is correlated with chronic hepatitis C nor does it predict response to therapy with interferon-alpha and ribavirin. |
| Q73593243 | Tumor necrosis factor alpha promoter polymorphisms at position -308 in Taiwanese chronic hepatitis C patients treated with interferon-alpha |
| Q37183637 | Tumor necrosis factor-alpha -308G/A polymorphism and risk of hepatocellular carcinoma in hepatitis C virus-infected patients |
| Q36143638 | Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma |
| Q37242781 | Tumor necrosis factor-α -G308A polymorphism is associated with liver pathological changes in hepatitis C virus patients |
| Q34040606 | Tumour necrosis factor -308 and -238 promoter polymorphisms are predictors of a null virological response in the treatment of Brazilian hepatitis C patients |